immune system
N |
• normal thymus and spleen histology
• normal numbers and kinetics of thymocytes and splenocytes
• normal percentage and number of germline proB (BP1- CD24-), DJ rearranged-proB (BP1- CD24+) or early preB cells (BP1+ CD24+) in CD43+ B220+ bone marrow cells
• normal percentage and number of late preB cells (IgD- IgM-), newly formed B cells (IgD- IgM+) or follicular-type recirculating B cells (IgD+ IgM+) in CD43- B220+ bone marrow cells
• normal Transitional 1 (T1) (CD21- IgM+ CD23-), Transitional 2 (T2) ) (CD21+ IgM+ CD23+) and mature follicular (Fo) (CD21+ IgM- CD23+) B cells in spleen
• normal immune response (IgM and IgG3 titers) to 2,4,6-trinitrophenyl-lipopolysaccharide (TNP-LPS)
• normal migration of spleen marginal zone B cells towards B lymphocyte chemoattractant (BLC) and SDF-1alpha
|
• narrowing of B cell region (B220+ region outside CD169+ MZ macrophages)
|
• reduction of percentage (in CD23- cells) and number of B cells (CD21+ IgM+ CD23-) in spleen
• normal Transitional 1 (T1) (CD21- IgM+ CD23-), Transitional 2 (T2) (CD21+ IgM+ CD23+) and mature follicular (Fo) (CD21+ IgM- CD23+) B cells
|
hematopoietic system
• narrowing of B cell region (B220+ region outside CD169+ MZ macrophages)
|
• reduction of percentage (in CD23- cells) and number of B cells (CD21+ IgM+ CD23-) in spleen
• normal Transitional 1 (T1) (CD21- IgM+ CD23-), Transitional 2 (T2) (CD21+ IgM+ CD23+) and mature follicular (Fo) (CD21+ IgM- CD23+) B cells
|
growth/size/body
N |
• no gross abnormalities
|
embryo
N |
• born at normal Mendelian ratio
|
mortality/aging
N |
• viable
|